The Indian rupee's direction this week will be shaped by the dollar's reaction to its recent correction and whether worries ...

India’s top officials said they will continue to cut import taxes as the government looks to work around US President Donald ...

As India and the United States navigate tense trade talks, President Trump’s threat of reciprocal tariffs looms large. Can ...

Indian pharmaceutical companies will be able to retain their dominant market share in the U.S. in selling generic drugs even ...

GTRI founder Ajay Srivastava explains that the threat of reciprocal tariffs is not cause of concern because 75 per cent of US ...

Commerce Department to hold sectoral consultations with other Ministries to sensitise them on India-US trade, tariff issues ...

US President Donald Trump questions the $21 million USAID funding to India for increasing voter turnout, suggesting that it ...

Andhra Pradesh has kept retail power tariffs unchanged for the fiscal year 2025-26, fulfilling a key election promise. The state government will provide a Rs 12,632.40 crore subsidy to cover the costs ...

Indian drugmakers earn a significant share of revenue from the United States, the largest importer of Indian pharma products.

India needs a transparent, institutional mechanism to look at both the short and long-term implications of tariffs. A nation ...

Finance Minister Nirmala Sitharaman emphasised that the duty cuts and rationalisation are part of a continuous process aimed ...